EGFR and head and neck squamous cell carcinoma: This manuscript contributes a new comprehension of the molecular heterogeneity of head and neck squamous cell carcinoma (HNSCC) and finds a way of potentially exploiting this heterogeneity through the demonstration that one subgroup (basal) is particularly sensitive to the EGFR blockade.